• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

Janssen Taps Komodo Health to Optimize Site Selection and Patient Recruitment for Clinical Trials

by Jasmine Pennic 03/31/2021 Leave a Comment

Komodo Health Acquires Cloud-Based Life Sciences Platform Mavens- M&A

What You Should Know: - Komodo Health today announced a new client engagement with Janssen solidifying its role as the leading life sciences patient data analytics platform. Janssen Research & Development, LLC (Janssen) will be using Komodo's real-world data and AI software to accelerate clinical development. Janssen plans to use Komodo's services to optimize feasibility, site selection and patient recruitment for clinical trials, ultimately driving higher throughput for
Read More

Next-Generation Cloud Storage: Enabling Collaboration & Analytics for Pharma Research

by Russ Kennedy, Chief Product Officer, Nasuni 03/29/2021 Leave a Comment

Next-Generation Cloud Storage: Enabling Collaboration & Analytics for Pharma Research

Pharmaceutical companies today are distributed, global organizations, with research centers, manufacturing facilities, and regulatory management hubs spread all over the globe. To develop new treatments and bring them to market, all of these different functions need to collaborate more closely than ever. Using traditional, on-premises storage technologies, however, makes it difficult to share data quickly and securely, especially given that the research and manufacturing process can generate
Read More

Why Families Need the Closure Whole Genome Sequencing Provides

by Haim Neerman, CEO of Variantyx 03/25/2021 Leave a Comment

Why Families Need the Closure Whole Genome Sequencing Provides

For medical practitioners expertly trained in the scientific methods of discovery, having a young patient with serious health complications from an undiagnosed condition is about as somber and frustrating as it gets. These feelings are only magnified for parents of the patient, especially when searching for a diagnosis can go on for years. This is the essence of what is known as the “diagnostic odyssey.” Honing in on a rare disease diagnosis involves thorough medical history evaluations,
Read More

Komodo Health Secures $220M for Life Sciences Data Platform at $3.3B Valuation

by Fred Pennic 03/22/2021 Leave a Comment

Komodo Health Acquires Cloud-Based Life Sciences Platform Nevis

What You Should Know: - Komodo Health announces $220M Series E investment to advance its enterprise healthcare and life sciences platform. At a $3.3 billion valuation, the investment underscores the company's rapidly growing role as a foundational enterprise technology platform helping to drive digital transformation across the healthcare industry.  - Founded in 2014, Komodo Health’s Healthcare Map™ is the industry’s largest and most complete record of
Read More

Variantyx Lands $20M for Whole Genome Sequencing Methodology

by Jasmine Pennic 03/15/2021 Leave a Comment

Variantyx Lands $20M for Whole Genome Sequencing Methodology

What You Should Know: - Variantyx, a Boston-based provider of high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing methodology, an advanced genetic testing method currently used to diagnose rare inherited and neurological disorders. The series C funding round was led by GHS Fund (Quark Venture LP and GF Securities) and includes new investor, IBM Ventures and current investors, Pitango
Read More

Exscientia Secures $100M To Expand AI Drug Discovery Platform

by Jasmine Pennic 03/04/2021 Leave a Comment

Exscientia Secures $100M To Expand AI Drug Discovery Platform

What You Should Know: - Exscientia, leading AI drug discovery company, today announced that it completed its $100 million Series C financing round, with a further $30 million investment from Blackrock. - This new capital, which will be used to support Exscientia's platform development and proprietary pipeline, follows Exscientia’s demonstrated high growth, having announced earlier this year that the first ever precision engineered drug designed using AI had entered Phase I human clinical
Read More

Life Sciences Firm OrbiMed Raises $3.5B Across Private Investment Funds

by Fred Pennic 03/01/2021 Leave a Comment

OrbiMed Launches $950M VC Fund

What You Should Know: Life sciences investment firm OrbiMed announced $3.5 billion in commitments for its latest private investment funds, including $1.5 billion for OrbiMed Private Investments VIII, $800 million for OrbiMed Asia Partners IV, and $1.2 billion for OrbiMed Royalty & Credit Opportunities III. The three new funds include a broad range of medical institutions, university endowments, foundations, pension funds and sovereign wealth funds. - OrbiMed Private Investments
Read More

Microsoft, UCB Launch Collaboration to Accelerate Drug Discovery and Development

by Fred Pennic 02/23/2021 Leave a Comment

Microsoft, UCB Launch Collaboration to Accelerate Drug Discovery and Development

What You Should Know: - Global biopharma company UCB and Microsoft announced today a new, multi-year strategic collaboration to advance UCB’s digital transformation, change the way care is delivered, and accelerate better outcomes for people living with severe diseases. - The partnership builds on the companies’ joint work as part of the COVID Moonshot project which sought to create an orally bioavailable anti-viral for COVID-19. During the project, UCB completed six
Read More

Illumina, Sequoia Capital China Launches Genomics Incubator in China

by Fred Pennic 02/01/2021 Leave a Comment

Illumina, Sequoia Capital China Launches Genomics Incubator in China

What You Should Know: - Illumina and Sequoia Capital will collaborate to build an ecosystem for life science startup companies advancing breakthrough applications in genomics. - Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina will leverage the expertise of Illumina for Startups in building genomics companies with the unparalleled track record of Illumina Accelerator in San Francisco Bay Area and Cambridge, UK. - Sequoia Capital China will dedicate to
Read More

Cellino Closes $16M Seed Financing led by The Engine and Khosla Ventures to Automate and Scale Stem Cell Manufacture

by Jasmine Pennic 02/01/2021 Leave a Comment

Cellino Closes $16M Seed Financing led by The Engine and Khosla Ventures to Automate and Scale Stem Cell Manufacture

What You Should Know: - Cellino, a Cambridge, MA-based personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced the closing of a $16M Seed financing round. The round was co-led by The Engine and Khosla Ventures, with participation from Humboldt Fund and 8VC. - The company’s platform solves a time-consuming, major bottleneck of developing drugs that rely on cell therapy, having to
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 71
  • Go to page 72
  • Go to page 73
  • Go to page 74
  • Go to page 75
  • Interim pages omitted …
  • Go to page 87
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |